(Q41554533)

3 October 2017

Increasing cellular immunogenicity to peptide-based vaccine candidates using a fluorocarbon antigen delivery system (English)

1 reference

3 October 2017

3

0 references

author name string

James N Francis

1

1 reference

3 October 2017

Jean-François Thaburet

2

1 reference

3 October 2017

Dominique Bonnet

3

1 reference

3 October 2017

Philip J Sizer

4

1 reference

3 October 2017

Carlton B Brown

5

1 reference

3 October 2017

Bertrand Georges

6

1 reference

3 October 2017

language of work or name

English

0 references

publication date

6 January 2015

1 reference

3 October 2017

1 reference

3 October 2017

33

1 reference

3 October 2017

8

1 reference

3 October 2017

1071-1076

1 reference

T-cell-inducing vaccines - what's the future

3 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

More than one reason to rethink the use of peptides in vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Self-adjuvanting lipopeptide vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Long-term CD4(+) and CD8(+) T-cell responses induced in HIV-uninfected volunteers following intradermal or intramuscular administration of an HIV-lipopeptide vaccine (ANRS VAC16).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Oxygen carriers ("blood substitutes")--raison d'etre, chemistry, and some physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

A novel peptide-based pan-influenza A vaccine: a double blind, randomised clinical trial of immunogenicity and safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Extension of HLA-A*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Stereochemical Dependence of the Self-Assembly of the Immunoadjuvants Pam3Cys and Pam3Cys-Ser

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Red blood cell substitutes: fluorocarbon emulsions and haemoglobin solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

Mechanisms of action of adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.12.061

10.1016/J.VACCINE.2014.12.061

7 January 2021

Identifiers

DOI

1 reference

3 October 2017

1 reference